A carregar...
Dosing strategies for switching from oral risperidone to paliperidone palmitate: Effects on clinical outcomes
INTRODUCTION: There are currently no guidelines for switching patients from oral risperidone to paliperidone palmitate (Invega Sustenna®). Furthermore, the paliperidone long-acting injectable (LAI) package insert does not recommend bridging with oral antipsychotics, which may result in inadequate se...
Na minha lista:
| Publicado no: | Ment Health Clin |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
College of Psychiatric & Neurologic Pharmacists
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007563/ https://ncbi.nlm.nih.gov/pubmed/29955505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.05.095 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|